Transvaginal Mesh Injuries

Have You Been Hurt By Transvaginal Mesh? Call 855-855-DZWL

What is Transvaginal Mesh?

A transvaginal mesh patch is a surgically implanted device that stretches across the vaginal wall to add extra support to internal organs that have been damaged. By adding strength to damaged vaginal walls, transvaginal mesh patches can be effective treatments for a number of conditions that may occur after childbirth and pregnancy. The conditions they are normally designed to correct include pelvic organ prolapse (POP) – a condition in which organs of the lower abdominal region slip out of place – and stress urinary incontinence (SUI), which is characterized by the inability to control urination when increasing pressure within the abdominal region. Unfortunately, a number of serious injuries have been reported in connection with these devices including mesh erosion, serious infection and the return of pelvic organ prolapse. To date, the U.S. Food & Drug Administration (FDA) has received nearly 4,000 reports of significant complications associated with transvaginal mesh patches. The failure of these products can lead to the need for multiple operations to remove the mesh and to repair extensive damage caused by the products.

Side Effects of Transvaginal Mesh

Patients implanted with transvaginal mesh products are at risk for serious complications. To date, the FDA has received nearly 4,000 reports of surgical mesh complications including:

  • Erosion of vaginal tissue
  • Infection
  • Mesh erosion
  • Pain
  • Perforations of the bowel, bladder or blood vessels
  • Recurrence of pelvic organ prolapse (POP) and stress urinary incontinence (SUI)
  • Urinary problems
  • Vaginal scarring

Pelvic Organ Prolapse (POP)

POP occurs when the internal structures that support the pelvic organs become so weak or stretched that they drop from their normal position and bulge into the vagina. Women suffering from POP often experience pelvic discomfort, disruption of sexual and urinary functions, and an overall reduction in their quality of life. Signs and symptoms of pelvic organ prolapse include:

  • Heaviness or pressure on the pelvis
  • Vaginal pain, pressure or bleeding
  • A bulge protruding from the vagina
  • Pain during intercourse
  • Urinary or fecal incontinence
  • Slow urinary stream or urinary urgency

A recent study published in the New England Journal of Medicine (NEJM) found that transvaginal mesh surgery was better at treating POP than colporrhaphy, a process that involves stitching the connective tissue in the vaginal wall back together. However, the procedure is not without risks, as many women have experienced excessive pain during sex, new urinary incontinence, and the need for revision surgery. The NEJM study found that approximately 3.5% of women who received transvaginal mesh suffered a bladder perforation during surgery, and nearly 13% suffered from urinary incontinence. Researchers also found that more than three percent of the women who received the mesh required revision surgery to correct exposure problems.

Though the study’s conclusions lend weight to the long-suspected link between transvaginal mesh patches and serious complications, they come as no surprise to many in the medical community. Complications involving transvaginal mesh products manufactured by several different companies have triggered numerous product liability lawsuits filed by patients who have fallen victim to infections, erosion of the vaginal mesh and other painful complications. A number of plaintiffs have alleged that companies neglected to design a safe product or properly warn the public of the inherent risks involved with the devices.

Transvaginal Mesh Manufacturers

Our law firm is currently accepting new transvaginal mesh claims against the following manufacturers:

Johnson & Johnson:

  • Ethicon TVT
  • Gynecare TVT
  • Gynemesh PS
  • Prolene Polypropylene Mesh Patch
  • Secur

Bard:

  • Avaulta Plus‚Ñ¢ BioSynthetic Support System
  • Avaulta Solo‚Ñ¢ Synthetic Support System
  • Faslata¬Æ Allograft
  • Pelvicol¬Æ Tissue
  • PelviSoft¬Æ Biomesh
  • Pelvitex‚Ñ¢ Polypropylene Mesh

American Medical Systems (AMS):

  • SPARC¬Æ

Boston Scientific:

  • Advantage‚Ñ¢ Sling System
  • Obtryx¬Æ Curved Single
  • Obtryx¬Æ Mesh Sling
  • Prefyx Mid U‚Ñ¢ Mesh Sling System
  • Prefyx PPS‚Ñ¢ System

FDA Warning on Transvaginal Mesh

In July 2011, the FDA issued a press release warning the public of significant complications linked to transvaginal mesh patches, some of which require revision surgery or may persist for the remainder of the woman’s life.

“There are clear risks associated with the transvaginal placement of mesh to treat POP,” said William Maisel, M.D., M.P.H., deputy director and chief scientist of the FDA’s Center for Devices and Radiological Health. “The FDA is asking surgeons to carefully consider all other treatment options and to make sure that their patients are fully informed of potential complications from surgical mesh. Mesh is a permanent implant ‚Äî complete removal may not be possible and may not result in complete resolution of complications.”

Plaintiff representation in personal injury litigation

Daryl Derryberry and Craig Zips are both Board Certified in Personal Injury Trial Law. If you are suffering complications from the use of transvaginal mesh products, contact the Texas law offices of Derryberry Zips Wade Lawhorn for a free consultation.